---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-26-000057"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2026-06-05T10:33:22+00:00"
generated_at: "2026-06-05T10:35:14.635311+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Haemonetics combines Plasma and Blood Center segments into Apheresis; Hospital renamed MedSurg

## Summary
- The new Apheresis segment combines formerly separate Plasma and Blood Center segments, effective Q1 FY2027.
- Hospital segment renamed MedSurg to better reflect underlying businesses, technologies, and markets.
- Supplemental presentation includes historical quarterly reconciliations from Q1 FY2024 to Q4 FY2026.
- FY2027 guidance recast under new segment structure; company not reaffirming or updating guidance.
- Updates, if any, to be provided on Q1 FY2027 earnings call.

## SEC filing metadata
- accession: 0000313143-26-000057
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2026-06-05T10:33:22+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314326000057/0000313143-26-000057-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314326000057/hae-20260605.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-26-000057
- JSON: https://secwatch.observer/filing/0000313143-26-000057.json
- Plain text: https://secwatch.observer/filing/0000313143-26-000057.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.